Downregulation of HOXC6 in Serous Ovarian Cancer

Cancer Invest. 2015;33(7):303-11. doi: 10.3109/07357907.2015.1041641. Epub 2015 Jun 5.

Abstract

Homeobox (HOX) genes encode transcription factors critical to morphogenesis and cell differentiation. Although dysregulation of several HOX genes in ovarian cancer has been reported, little is known about HOXC6 expression in epithelial ovarian cancer. In this report, analysis of laser capture microdissected samples determined HOXC6 expression patterns in normal versus malignant serous ovarian carcinoma tissues. HOXC6 protein was quantified by ELISA in parallel serum samples and further validated in a larger cohort of serum samples collected from women with and without serous ovarian carcinoma. These data demonstrate significant downregulation of HOXC6 in serous ovarian cancer.

Keywords: Biomarker discovery; HOXC6; Homeobox genes; Serous ovarian cancer.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Ovarian Epithelial
  • Cell Line, Tumor
  • Cystadenocarcinoma, Serous / blood*
  • Cystadenocarcinoma, Serous / pathology
  • Down-Regulation
  • Female
  • Gene Expression Regulation, Neoplastic
  • HeLa Cells
  • Homeodomain Proteins / genetics*
  • Homeodomain Proteins / metabolism*
  • Humans
  • Middle Aged
  • Neoplasms, Glandular and Epithelial / blood*
  • Neoplasms, Glandular and Epithelial / pathology
  • Oligonucleotide Array Sequence Analysis
  • Ovarian Neoplasms / blood*
  • Ovarian Neoplasms / pathology

Substances

  • HOXC6 protein, human
  • Homeodomain Proteins